Jump to content
View in the app

A better way to browse. Learn more.

Surly Horns

A full-screen app on your home screen with push notifications, badges and more.

To install this app on iOS and iPadOS
  1. Tap the Share icon in Safari
  2. Scroll the menu and tap Add to Home Screen.
  3. Tap Add in the top-right corner.
To install this app on Android
  1. Tap the 3-dot menu (⋮) in the top-right corner of the browser.
  2. Tap Add to Home screen or Install app.
  3. Confirm by tapping Install.
Football ... Basketball ... Baseball ... Other Sports ... Futbol ... 🤫995🤫 ... Gambling ... Movies & TV ... Music ... Hobbies ... Lulz ... Food & Travel ... Daily Texan ... Business & Markets ... Cloak Room ... Help ... For Sale ... Board Discussion ... Advertise... Tailgate Donations

Featured Replies

UUUU feels like the type of stock where you just set limit orders to buy at $6 and sell at $7.50.  Rinse, repeat 2-3x per year.  

  • Replies 10.6k
  • Views 757.4k
  • Created
  • Last Reply

Top Posters In This Topic

Most Popular Posts

  • Haven't mentioned it because didn't need naysayers because it is stupid, but I'm a med student doing this almost purely on my student loans while they're at zero interest. I've made +$20k since Decemb

  • The real treasure is the friends we make along the way

  • As long as 700% APR payday loans exist, you can fuck right off with "protecting people from themselves".

Posted Images

15 hours ago, Harrison Stafford said:

As at October 2023, RecycLiCo Battery Materials (AMYZF) had cash of CA$19m and no debt. In the last year, its cash burn was CA$4.4m. Based on that, from October 2023 it has 4.3 years of cash runway.  This has been a horrible investment, but it ain’t over.

Hell no it aint over, they just gave their board of directors another 12M stock options with an exercise price of $0.19. There's still years of stock issuances and milking this bitch. 

https://recyclico.com/recyclico-grants-stock-options-2/

Edited by Blotto

4 hours ago, Blotto said:

Hell no it aint over, they just gave their board of directors another 12M stock options with an exercise price of $0.19. There's still years of stock issuances and milking this bitch. 

https://recyclico.com/recyclico-grants-stock-options-2/

And AMYZF has to about double from here for the rights to be in the money.  That’s a start.

9 minutes ago, Harrison Stafford said:

And AMYZF has to about double from here for the rights to be in the money.  That’s a start.

Lulz. 3 years ago the stock was trading at around $2. Management now wants to reward themselves if they can hype the stock price above $0.20 which is where it was about 2 months ago. Handed out another 5% of the company to celebrate such a glorious goal. Exhibit A why they have kept this scam going since the 80's with no revenue. Because they can. 

  • Author
14 hours ago, Blotto said:

Lulz. 3 years ago the stock was trading at around $2. Management now wants to reward themselves if they can hype the stock price above $0.20 which is where it was about 2 months ago. Handed out another 5% of the company to celebrate such a glorious goal. Exhibit A why they have kept this scam going since the 80's with no revenue. Because they can. 

It worked!!!!!

AMY is up over 20%, (which sounds great, until you realize that is just about 2 cents and it is still under $0.15). 
Now if it will only go up a meer 4X from here to get to almost even; can't believe they are handing out more options at these prices.
I did average down in December, so I am only down 80% at this time, and "only" down 8.5% on the recent purchase  

3 minutes ago, Wally Fairway said:

It worked!!!!!

AMY is up over 20%, (which sounds great, until you realize that is just about 2 cents and it is still under $0.15). 
Now if it will only go up a meer 4X from here to get to almost even; can't believe they are handing out more options at these prices.
I did average down in December, so I am only down 80% at this time, and "only" down 8.5% on the recent purchase  

I would guess its a slam dunk that the price temporarily spikes back over $.30 in the next couple of months now that the next crop of options have been planted. Look for a fresh round of ambiguous PR with updates about sample purity or another JV with a company nobody has heard of. Everyone can cash out, the price settles back down, they issue more  options and the cycle starts anew. TBH, its a good gig. Those dudes must have shit themselves when the price spiked to $2 in the great microcap runup of early 2021. 

17 hours ago, Harrison Stafford said:

And AMYZF has to about double from here for the rights to be in the money.  That’s a start.

200.gif

 

8X gets me even... lets go!!!

 

Need to start paying attention to when the shareholder meeting is so I can submit some sternly worded notes.

 

1 hour ago, Blotto said:

Those dudes must have shit themselves when the price spiked to $2 in the great microcap runup of early 2021. 

Rolling Pay Day GIF by G2 Esports

20 hours ago, Blotto said:

Lulz. 3 years ago the stock was trading at around $2. Management now wants to reward themselves if they can hype the stock price above $0.20 which is where it was about 2 months ago. Handed out another 5% of the company to celebrate such a glorious goal. Exhibit A why they have kept this scam going since the 80's with no revenue. Because they can. 

AMYZF +.04 to .15. A 38% move.  You bash the stock and up it goes.  Can we haz u come back every trading day?

6 minutes ago, Harrison Stafford said:

AMYZF +.04 to .15. A 38% move.  You bash the stock and up it goes.  Can we haz u come back every trading day?

You dont need my help. With this fresh bunch of options granted, they will be pumping the shit out of this stock with press releases. They've hacked a cheat code. Why waste effort and money on developing a revenue stream, when they can just keep their payroll and R&D to around $200K per quarter and issue millions of stock options. 

image.png.78128dd93acacd01bb2f618cf7359ad8.png

 

 

5 hours ago, Blotto said:

I would guess its a slam dunk that the price temporarily spikes back over $.30 in the next couple of months now that the next crop of options have been planted. Look for a fresh round of ambiguous PR with updates about sample purity or another JV with a company nobody has heard of. Everyone can cash out, the price settles back down, they issue more  options and the cycle starts anew. TBH, its a good gig. Those dudes must have shit themselves when the price spiked to $2 in the great microcap runup of early 2021. 

https://recyclico.com/recyclico-battery-materials-and-zenith-chemical-announce-a-us25-million-lithium-ion-battery-recycling-joint-venture-in-taiwan/
Ever heard of Zenith?

16 minutes ago, Harrison Stafford said:

Sure I've heard of Zenith Electronics. Not sure what that has to do with some obscure chemical company in Taiwan with 30 employees: http://www.zenith.com.tw/

 

Edited by Blotto

SMCI was just added to the S&P 500 and is currently going nuts after hours.  19% so far.  How far do I ride this thing?  

12 minutes ago, Harrison Stafford said:

We’re on opposite sides of this trade.  Let’s see who gets the last laugh.

I'm not on any side of this trade as sold my my shares a couple of years ago once it became clear that revenue wasn't a priority for this company. Ive only shit on three companies consistently on this thread: HMBL, ALPP, and AMYZF. I was right on the first two, I guess we'll see on AMY. 

4 minutes ago, Your Mom said:

SMCI was just added to the S&P 500 and is currently going nuts after hours.  19% so far.  How far do I ride this thing?  

If you’re asking, it’s probably time to get off.

2 minutes ago, Blotto said:

I'm not on any side of this trade as sold my my shares a couple of years ago once it became clear that revenue wasn't a priority for this company. Ive only shit on three companies consistently on this thread: HMBL, ALPP, and AMYZF. I was right on the first two, I guess we'll see on AMY. 

So, you come on here, shit on a stock, but you won’t even take a short position?  

5 minutes ago, Harrison Stafford said:

So, you come on here, shit on a stock, but you won’t even take a short position?  

Lulz, who the fuck would short a pink sheet  stock with a market cap bouncing around $30 million thats been around since 1987 with no revenue. I see no reason they cant keep it for another 10-20 years.

31 minutes ago, Blotto said:

Lulz, who the fuck would short a pink sheet  stock with a market cap bouncing around $30 million thats been around since 1987 with no revenue. I see no reason they cant keep it for another 10-20 years.

I have skin in the game and you have no skin in the game. Let’s see who gets the last laugh.

  • Author
On 3/1/2024 at 7:36 PM, Your Mom said:

SMCI was just added to the S&P 500 and is currently going nuts after hours.  19% so far.  How far do I ride this thing?  

I will answer your question with a question - what was your goal/target when you bought it? If you have exceeded that target, then take some off the table. 
I can tell you from more experience than it should have taken, that it is worse to watch gains erode due to greed/fear/stupidity and then hold hoping for the comeback. 
At least take enough off the table to cover the cost of buying into it; nothing wrong with holding longterm, but at some point you will need to diversify which is a soft way of saying selling your winners

  • Author
On 3/1/2024 at 5:44 PM, Harrison Stafford said:

AMYZF +.04 to .15. A 38% move.  You bash the stock and up it goes.  Can we haz u come back every trading day?

Up almost another .02 (12%) so far today - only thing I own that is green  today. Run AMY Run. 
(yeah I know - jinxing jinxer shit)

On 3/1/2024 at 6:36 PM, Your Mom said:

SMCI was just added to the S&P 500 and is currently going nuts after hours.  19% so far.  How far do I ride this thing?  

Up 24% today.

💎

23 hours ago, WBT said:

Up 24% today.

💎

Yep.  I’ve been popping in and out a little bit.  I have no desire to watch it all day every day, but after each big jump lately I’ve been getting out and then getting back in at the next days dip.  Got out yesterday at 1136 and back in today at 998.  Other than a few excursions like that I’m keeping this at least through the next earnings release.  

GERN’s AdCom date is this Thursday. March 14th.  That committee will decide if GERN’s drug, Imetelstat, should be submitted to the FDA for approval.  I think the drug works. Lengthening the time between transfusions generally increases survival. Imetelstat treats the cause not just the symptoms and is therefore a disease modifying drug. And, if this one gets recommended and approved, the next phase 3 is treating myelofibrosis using the same drug… It should be approved as well. So, if there’s a green light for GERN on Thursday, I expect the stock to move a couple bucks (it’s currently at $2.23).  It’s the FDA decision that will have the biggest impact on the share price.  The PDUFA, target date is in May, but after AdCom, the FDA doesn’t have to wait that long to make a decision and they could decide to give the drug approval much earlier.  Have owned GERN for eleven l-o-n-g years and we’re at the finish line.  If Imetelstat is not approved, it’s likely the beginning of the end for Geron.  This is Biotech and it’s as close as you can get to a casino.  Long GERN 6000 shares at a cost basis of $3.19.  
 

IBRX +.48 to $5.53.  The PDUFA date for IBRX’s drug, Anktiva, is April 23rd.  Anktiva has, virtually, no side effects and is better than the current standard of care…..what’s not to like.  Long IBRX 27,800 shares at a cost basis of $9.77.  

9 hours ago, Harrison Stafford said:

GERN’s AdCom date is this Thursday. March 14th.  That committee will decide if GERN’s drug, Imetelstat, should be submitted to the FDA for approval.  I think the drug works. Lengthening the time between transfusions generally increases survival. Imetelstat treats the cause not just the symptoms and is therefore a disease modifying drug. And, if this one gets recommended and approved, the next phase 3 is treating myelofibrosis using the same drug… It should be approved as well. So, if there’s a green light for GERN on Thursday, I expect the stock to move a couple bucks (it’s currently at $2.23).  It’s the FDA decision that will have the biggest impact on the share price.  The PDUFA, target date is in May, but after AdCom, the FDA doesn’t have to wait that long to make a decision and they could decide to give the drug approval much earlier.  Have owned GERN for eleven l-o-n-g years and we’re at the finish line.  If Imetelstat is not approved, it’s likely the beginning of the end for Geron.  This is Biotech and it’s as close as you can get to a casino.  Long GERN 6000 shares at a cost basis of $3.19.  
 

IBRX +.48 to $5.53.  The PDUFA date for IBRX’s drug, Anktiva, is April 23rd.  Anktiva has, virtually, no side effects and is better than the current standard of care…..what’s not to like.  Long IBRX 27,800 shares at a cost basis of $9.77.  

The real treasure was the friends we made along the way.

  • Author
10 hours ago, Coelenterate Fuccboi said:

The real treasure was the friends we made along the way.

 

24 minutes ago, Harrison Stafford said:

Making friends and making money.   Why not both?

More like making friends while bonding over the shared life experience of losing money on shared stonk investments

20 hours ago, Wally Fairway said:

Investing is like riding a roller coaster

 I like the roller coaster ride...

I just want to lounge in a hot tub full of cash.

Scrooge Mcduck Trump GIF

On 3/8/2024 at 2:00 PM, Harrison Stafford said:

GERN’s AdCom date is this Thursday. March 14th.  That committee will decide if GERN’s drug, Imetelstat, should be submitted to the FDA for approval.  I think the drug works. Lengthening the time between transfusions generally increases survival. Imetelstat treats the cause not just the symptoms and is therefore a disease modifying drug. And, if this one gets recommended and approved, the next phase 3 is treating myelofibrosis using the same drug… It should be approved as well. So, if there’s a green light for GERN on Thursday, I expect the stock to move a couple bucks (it’s currently at $2.23).  It’s the FDA decision that will have the biggest impact on the share price.  The PDUFA, target date is in May, but after AdCom, the FDA doesn’t have to wait that long to make a decision and they could decide to give the drug approval much earlier.  Have owned GERN for eleven l-o-n-g years and we’re at the finish line.  If Imetelstat is not approved, it’s likely the beginning of the end for Geron.  This is Biotech and it’s as close as you can get to a casino.  Long GERN 6000 shares at a cost basis of $3.19.  
 

IBRX +.48 to $5.53.  The PDUFA date for IBRX’s drug, Anktiva, is April 23rd.  Anktiva has, virtually, no side effects and is better than the current standard of care…..what’s not to like.  Long IBRX 27,800 shares at a cost basis of $9.77.  

GERN down 18% today to $1.75.

 

Those March call options on the $2.50 strike for $.21 seem like a half decent basketball wager.  

If the AdCom committee doesn’t approve GERN’s, Imetelstat, on an eight week transfusion argument, they need to revoke BMY‘s drug approval of, Luspatercept, which used the same milestone.  Luspatercept’s efficacy is a quarter of that of Imetelstat and the study used less sick patients.

  • Author
On 3/12/2024 at 2:52 PM, Trey3216 said:

GERN down 18% today to $1.75.

 

Those March call options on the $2.50 strike for $.21 seem like a half decent basketball wager.  

 

15 minutes ago, Harrison Stafford said:

If the AdCom committee doesn’t approve GERN’s, Imetelstat, on an eight week transfusion argument, they need to revoke BMY‘s drug approval of, Luspatercept, which used the same milestone.  Luspatercept’s efficacy is a quarter of that of Imetelstat and the study used less sick patients.

On the other hand - the drop in this stonk is dropping couple of days like someone really wants out starting at $2.40 and continuing. That being said what Trey posted has my interest up... (don't do it Wally, swear to god it would suck to pull the trigger

9 minutes ago, Wally Fairway said:

 

On the other hand - the drop in this stonk is dropping couple of days like someone really wants out starting at $2.40 and continuing. That being said what Trey posted has my interest up... (don't do it Wally, swear to god it would suck to pull the trigger

YOLO!

Fuck it, I went and bought a GERN lottery ticket at 1.70 today.  That should ensure a terrible hearing tomorrow.

  • Author
1 hour ago, Hefeweizen said:

Fuck it, I went and bought a GERN lottery ticket at 1.70 today.  That should ensure a terrible hearing tomorrow.

This is the way

Only question is, ALPP of 2020 or 2023?  How big of a bag of shit did I buy will be revealed soon.

I'm semi-intrigued by Kevin Plank moving back into the CEO position at Under Armour with Mohammed El-Erian taking a place on the Board.  January '25 $10c seems like a half solid play.   

  • Author
2 minutes ago, Harrison Stafford said:

GERN will probably be halted all day,

FAFO

 

money-to-burn-money.gif

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...
Football ... Basketball ... Baseball ... Other Sports ... Futbol ... 🤫995🤫 ... Gambling ... Movies & TV ... Music ... Hobbies ... Lulz ... Food & Travel ... Daily Texan ... Business & Markets ... Cloak Room ... Help ... For Sale ... Board Discussion ... Advertise... Tailgate Donations

Configure browser push notifications

Chrome (Android)
  1. Tap the lock icon next to the address bar.
  2. Tap Permissions → Notifications.
  3. Adjust your preference.
Chrome (Desktop)
  1. Click the padlock icon in the address bar.
  2. Select Site settings.
  3. Find Notifications and adjust your preference.